Lv1
40 积分 2023-06-26 加入
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
15天前
已完结
Claudin 18.2 as a novel therapeutic target
17天前
已完结
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy
1个月前
已完结
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy
1个月前
已完结
A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience
1个月前
已完结
Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study
1个月前
已关闭
The Utility of Patient Engagement in Drug Research and Development
1个月前
已完结
Novel strategies to manage CAR-T cell toxicity
1个月前
已完结
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing
1个月前
已完结
Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma
2个月前
已完结
不同加工方法梅花鹿鹿茸中尿嘧啶等五种核苷成分的含量分析
1年前
已采纳
皖公网安备34019202002308
